Our Work


Phenomenal advances in targeted therapy over the past ten years have had a significant impact on breast cancer survival.  Within these excellent survival rates however lie a significant group of patients (>30%) who will have disease recurrence.  The challenge now is to understand why…


  • Our Focus

    Our challenge is to understand why breast cancer recurrences happen and to ensure that metastatic disease is detected early and treated effectively. The ability of a tumour to alter its status following treatment is clinically accepted and our team are working to identify gene determinants that can be used as biomarkers in helping to improve... View Article